Lotus Pharmaceutical Co., Ltd. (TPE:1795)
101.50
-10.00 (-8.97%)
Nov 20, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 27.04 billion as of November 20, 2026. It is the 10,574th most valuable company in the world and the 286th biggest in Taiwan. Its market cap has decreased by 63.53% in one year.
Market Cap
27.04B
Enterprise Value
78.74B
Revenue
31.08B
Global Rank
Country Rank
#286 Taiwan
PE Ratio
12.08
ChartMarket Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 27.04B, an increase of 194.35%. That is a compound annual growth rate of 9.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 27.04B | -63.66% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 35.72B |
| Center Laboratories | 19.50B |
| TTY Biopharm Company | 19.27B |
| YungShin Global Holding | 15.08B |
| Handa Pharmaceuticals | 13.38B |
| ScinoPharm Taiwan | 13.32B |
| Synmosa Biopharma | 13.15B |
| Foresee Pharmaceuticals | 10.54B |